NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1194145250 MD
Verify on CMS → Samir Panvelker, MD
Endocrinology, Diabetes & Metabolism Physician in Cherry Hill, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 399 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
42%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
86.8/100
▲ 3 pts above national avg 83.5 · Above neutral
Industry payments
$393.18
17 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Samir Panvelker, MD reported a CMS MIPS final score of 86.8/100 - above the 83.5 national average - and filed 1,617 Medicare Part D claims in 2024.
- 86.8/100
- MIPS score · +3 vs avg
- 2K
- Part D claims, 2024
- 42%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Samir Panvelker, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1194145250), first enumerated 04/16/2014.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,617 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 86.8/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$393.18 in reported industry payments (17 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1194145250 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1194145250
- ENUM-MID 2014
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-ABOVE 86.8/100
- RX-MID 1,617
- BOOK-THIN 330 in New Jersey
- PHOTO-FINISH John Turco · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Linda Bundy · lo…
Linda Bundy
86.7 MIPS pts
- Panvelker · this…
Panvelker · this provider
86.8 MIPS pts
- John Turco · hig…
John Turco
86.8 MIPS pts
- Susan Gerber · n…
Susan Gerber
86.8 MIPS pts
- Alan Schorr · near
Alan Schorr
86.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Samir Panvelker, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
87 ≥ 49th percentile 49% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Samir Panvelker, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Samir Panvelker, MD writes more Part D claims than 39% of them and scores higher on MIPS quality than 54% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Samir Panvelker, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Samir Panvelker, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Samir Panvelker, MD?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,617 41% vs specialty avg
MIPS final score
86.8/100 3.3 pts vs avg
Specialty distribution in New Jersey
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Samir Panvelker, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 86.8/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1194145250 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/16/2014 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
86.7523
Final Score
Measured-score avg: 83.5
75.9132
Quality
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Samir Panvelker, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Cmc Department OF Medicine Group PA
Cherry Hill, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Samir Panvelker, MD. Source: openpaymentsdata.cms.gov.
Total received
$393
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Samir Panvelker, MD - brand share 47.0%
Endocrinology, Diabetes & Metabolism Physician average
47% brand-name claims vs 42% generic, on 1,617 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,617
Total Claims
$679K
Total Drug Cost
399
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,460.033
- Total Day Supply
- 102,099
- Brand vs Generic
- 47% brand / 42% generic
- Brand Drug Cost
- $646K
- Generic Drug Cost
- $15K
Patient Demographics
- Average Patient Age
- 69.8 years
- Avg HCC Risk Score
- 1.82
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 83, 65-74: 182, 75-84: 120, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Samir Panvelker, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
175 claims
- Ozempic
Ozempic
147 claims
- Metformin Hcl
Metformin Hcl
106 claims
- Metformin Hcl Er
Metformin Hcl Er
101 claims
- Lantus Solostar
Lantus Solostar
80 claims
- Jardiance 62
Jardiance
62 claims
- Farxiga 56
Farxiga
56 claims
- Pioglitazone Hcl 43
Pioglitazone Hcl
43 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 175 |
| Ozempic Semaglutide | 147 |
| Metformin Hcl | 106 |
| Metformin Hcl Er Metformin Hcl | 101 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 80 |
| Jardiance Empagliflozin | 62 |
| Farxiga Dapagliflozin Propanediol | 56 |
| Pioglitazone Hcl | 43 |
| Hydrocortisone | 39 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 37 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in NJ →
All providers in New Jersey →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Samir Panvelker, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Samir Panvelker, MD's 1,617 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Panvelker, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (86.8 here).
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Panvelker.
One of 330 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Alice Abraham
M.D.
Englewood, NJ
Dr. Sonoo Advani
M.D.
West Orange, NJ
Dr. Karen Agersborg
DO
Cape May Court House, NJ
Dr. Richard Agrin
MD
New Brunswick, NJ
Dr. Sana Ahsun
MD
Piscataway, NJ
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Samir Panvelker, MD's specialty? ▼
Samir Panvelker, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Cherry Hill, New Jersey. Credentials: MD.
How much does Samir Panvelker, MD prescribe under Medicare Part D? ▼
In 2024, Samir Panvelker, MD wrote 1,617 Medicare Part D claims totaling $679K in drug costs for 399 beneficiaries.
What is Samir Panvelker, MD's Medicare quality score? ▼
Samir Panvelker, MD has a CMS MIPS Final Score of 86.8/100 (Quality: 75.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Samir Panvelker, MD located? ▼
Samir Panvelker, MD is located at 2339 ROUTE 70 W STE 300, Cherry Hill, NJ, 08002. Phone: (856) 795-3597.
What is Samir Panvelker, MD's NPI number? ▼
Samir Panvelker, MD's National Provider Identifier (NPI) is 1194145250, issued on 04/16/2014.
Does Samir Panvelker, MD prescribe more brand-name or generic drugs? ▼
Samir Panvelker, MD's prescribing is 47% brand-name and 42% generic drugs by claim count, with $646K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Samir Panvelker, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Samir Panvelker, MD's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Samir Panvelker, MD accept Medicare? ▼
Samir Panvelker, MD appears in CMS Medicare data with 1,617 Part D claims and 399 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Samir Panvelker, MD's credentials? ▼
Samir Panvelker, MD's NPI is 1194145250 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.